BioInvent International
28.10.2021 08:31:40 CEST | ACCESS Newswire | Press release
LUND, SWEDEN / ACCESSWIRE / October 28, 2021 / BioInvent International (STO:BINV)
"The powerful combination of BioInvent's R&D and in-house manufacturing provides invaluable support to our clinical development and facilitates the execution of our current clinical portfolio. The integration of functions, on top of world leading science, makes it possible for us to develop novel treatments for patients suffering from serious diseases. The solid balance sheet and strong, loyal shareholders support us in achieving our goals," said Martin Welschof, BioInvent CEO.
Events in the quarter
• (R) BioInvent announced a second clinical trial collaboration and supply agreement with Merck to evaluate BI-1808 in combination with Keytruda® (pembrolizumab) in patients with advanced solid tumors.
• Emma Meurling joined Bioinvent as Human Resource (HR) Director.
Events after the period
• BioInvent and Transgene announced that preclinical data for BT-001, a novel oncolytic virus delivering an anti-CTLA-4 antibody for the treatment of solid tumors, will be presented at SITC in November 2021.
• New data on the lead drug candidate BI-1206 Phase 1/2a study in non-Hodgkin's lymphoma (NHL) to be presented at the ASH (American Society of Hematology) conference December 11-14.
• New production agreement with CRUK to produce additional batch of anti-HER3 antibody.
• Prof. Eggermont new member of the BioInvent Scientific Advisory Board.
Financial information
Third quarter 2021
• Net sales SEK 3.0 (16.3) million.
• Loss after tax SEK -62.6 (-32.9) million.
• Loss after tax per share before and after dilution SEK -1.07 (-1.00).
• Cash flow from operating activities -57.5 (-31.4) million.
January - September 2021
• Net sales SEK 14.5 (48.6) million.
• Loss after tax SEK -199.7 (-104.9) million.
• Loss after tax per share before and after dilution SEK -3.79 (-4.00).
• Cash flow from operating activities SEK -170.1 (-91.8) million.
• Liquid funds and long-term investments as of September 30, 2021: SEK 1,445.3 (642.1) million.
The complete report is attached as pdf and is available on the company's website www.bioinvent.com/investors/#financialreports.
(R)= Regulatory event
Contacts
Cecilia Hofvander
Senior Director Investor Relations
Tel: +46 46 286 85 50
Email. cecilia.hofvander@bioinvent.com
About Us
BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently three drug candidates in four ongoing clinical programs in Phase 1/2 trials for the treatment of hematological cancer and solid tumors, respectively. The Company's validated, proprietary F.I.R.S.T™ technology platform simultaneously identifies both targets and the antibodies that bind to them, generating many promising new drug candidates to fuel the Company's own clinical development pipeline or for additional licensing and partnering.
The Company generates revenues from research collaborations and license agreements with multiple top-tier pharmaceutical companies, as well as from producing antibodies for third parties in the Company's fully integrated manufacturing unit. More information is available at www.bioinvent.com. Follow us on Twitter: @BioInvent.
Attachments
SOURCE: BioInvent International
View source version on accesswire.com:
https://www.accesswire.com/670065/BioInvent-International-AB-Interim-Report-January--September-2021
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Symetrix Unveils Cognio: The Next-Generation Audio, Video, and Control Platform27.1.2026 14:15:00 CET | Press release
With breakthrough distributed architecture and wire-free design workflows, Cognio redefines how AV systems are designed, deployed, and operated; see it for the first time at ISE 2026 SEATTLE, WA / ACCESS Newswire / January 27, 2026 / Symetrix, a global leader in high-performance AV processing, control, and monitoring solutions, today announced the launch of Cognio™, a brand-new software-driven Audio, Video, and Control (AVC) ecosystem designed to dramatically simplify system design, accelerate deployment, and deliver more flexible, scalable AV experiences. Cognio will make its official public debut at Integrated Systems Europe (ISE) 2026 in Barcelona, where attendees can experience an entirely new approach to deploying Audio, Video, and Control solutions at the Symetrix booth (5M390). Cognio represents a fundamental rethinking of how AV systems are built, combining distributed intelligence with code-free control into a single platform powered by DesignOps, the patented software that un
U.S. Polo Assn. Celebrates a Landmark Debut as the Official Jersey and Apparel Partner of the 41st Snow Polo World Cup St. Moritz27.1.2026 13:00:00 CET | Press release
Standing Rock Claims Victory Over Flexjet in a Thrilling Final Showdown WEST PALM BEACH, FL AND ST. MORITZ, SWITZERLAND / ACCESS Newswire / January 27, 2026 / U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), celebrated its inaugural year as the Official Jersey and Apparel Partner of the 41st Snow Polo World Cup St. Moritz. The legendary three-day competition and record-breaking lifestyle event took place on the iconic frozen Lake St. Moritz in Switzerland's Engadin Valley and featured world-class competition, alpine elegance, fan activations, VIP experiences, and global sport celebration. More than 2,400 tons of infrastructure were installed directly onto the frozen lake of St. Moritz for this one-of-a-kind event. After two days and eight games of preliminaries, on Sunday, Jan. 25, Standing Rock prevailed over Flexjet in a close 6 - 4.5 victory.1. The intensity was high in the final Snow Polo World Cup game, with Standing Rock ultimately prevaili
AM Positions for Next Phase of Global Growth: Kelly McAndrew to Chairman; Dave Watrous to CEO27.1.2026 07:00:00 CET | Press release
AUSTIN, TX / ACCESS Newswire / January 27, 2026 / For over 21 years, Kelly McAndrew has served as Chief Executive Officer (CEO), playing a pivotal role in shaping AM Technical Solutions (AM) culture and strategic direction, enabling exceptional results. Kelly now transitions into the role of Chairman of the Board. As Chairman, Kelly will focus on investments and partnerships to further enhance the company's solution offerings. Dave Watrous will succeed Kelly as Chief Executive Officer. AM has worked closely with Dave for more than six years in the roles of customer and partner. His faith, integrity, leadership qualities, and strong industry expertise make him the ideal choice for this role. With a distinguished 30-year career in High-Technology industries, Dave brings extensive capabilities in delivering multi-billion-dollar Engineering, Procurement, Construction, Commissioning, and Validation projects worldwide. As CEO, Dave will focus on leading growth, accelerating opportunities, en
Richter Extends Its Support to Africa - The First Year of the House of Hope in Bamako in Numbers26.1.2026 14:00:00 CET | Press release
The First Year of the House of Hope in Bamako in Numbers BUDAPEST, HU / ACCESS Newswire / January 26, 2026 / Nearly one year has passed since the House of Hope centre, established by Richter Gedeon Plc., began providing shelter and comprehensive support to women in Bamako. During this period, almost 120 women and girls have benefited from healthcare, legal aid and education. Interest in the centre remains strong, with new women continuously joining the programme. In the coming years, the initiative aims to reach several hundred vulnerable women across different regions of Mali. Why Was the House of Hope Established? The centre was created through the collaboration of Richter Gedeon Plc. (Richter), the Hungary-based Close to Africa Foundation, and the local Sini Sanuman Foundation. Its mission is to provide safety and professional support to women fleeing violence and abuse through gynaecological care, psychological and legal counselling, and educational programmes. The building was des
TIS Appoints New CEO to Accelerate Global Growth26.1.2026 13:00:00 CET | Press release
BERLIN, DE / ACCESS Newswire / January 26, 2026 / Treasury Intelligence Solutions (TIS), a leading cloud-based platform for payments and cash management, today announced Zlatko Vucetic as the new Chief Executive Officer (CEO) effective from February 1, 2026. This move comes as a pivotal step in advancing the company's long-term vision and global growth strategy in cloud-native cash management, liquidity, and payment solutions. As an experienced CEO, Zlatko brings a strong track record in scaling software companies across Europe, Asia, and the U.S., combined with deep expertise in driving innovation and accelerating growth in competitive markets. Zlatko will lead TIS in its journey to be a market leader in payment and liquidity management across Europe and North America. After five successful years as CEO, Erik Masing will transition into the role of Vice Chair of the Board, where he will continue to provide strategic guidance and support. Under Erik's leadership, TIS achieved significa
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom